0QB4.L
Medios AG [0QB4.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0QB4.L Stock Summary
In the News
0QB4.L Financial details
Company Rating
-
Market Cap
363.27M
Income
18.81M
Revenue
1.78B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
333
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
19.35
Forward P/E
-
PEG
74.5
P/S
-
P/B
0.78
P/C
-
P/FCF
0.08
Quick Ratio
1.81
Current Ratio
2.55
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.79
EPS next Y
-
EPS next Q
-
EPS this Y
2.6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.35%
Revenue last 5Y
28.13%
Revenue Q/Q
-9.94%
EPS Q/Q
-66.67%
-
-
-
-
SMA20
-13.52%
SMA50
-9.51%
SMA100
-25.65%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.06%
Gross Margin
6%
Oper. Margin
2%
Profit Margin
1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
13.3-20.6
52W High
-43.3%
52W Low
-12.77%
RSI
43.68
Rel Volume
-
Avg Volume
8.91K
Volume
14
Perf Week
4.13%
Perf Month
-7.35%
Perf Quarter
-
Perf Half Y
-25.39%
-
-
-
-
Beta
1.071
-
-
Volatility
0.3%, 0.89%
Prev Close
-1.05%
Price
11.34
Change
-4.14%
Company Profile
- Volume Average 8.91K
- Market Capitalization 363.27M
- Employee 333
- CEO Mr. Matthias Gaertner
- Headquarters Berlin,DE
- IPO Date 2017-11-07
-
Website
https://www.medios.ag 
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
